DSSTox_CID_3636

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

130 API Suppliers, 40 USDMF, 40 CEP/COS, 19 JDMF, 37 EU WC, 42 KDMF, 23 NDC API, 72 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

38 Suppliers

38 Suppliers

DOSSIERs // Finished Dosage Formulations

782 Dossiers, 104 FDA Orange Book, 354 Europe, 65 Canada, 35 Australia, 43 South Africa, 181 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;80MG, TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG
TABLET;ORAL - 40MG
TABLET;ORAL - 80MG
TABLET;ORAL - 12.5MG;40MG
TABLET;ORAL - 12.5MG;80MG
TABLET;ORAL - 25MG;80MG
TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 37 Kerry, 29 Roquette, 18 SPI Pharma, 15 Microlex e.U, 14 BASF, 13 Gangwal Healthcare, 12 Sigachi Industries, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 8 Gangwal Chemicals, 7 DFE Pharma, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Seppic, 7 Boai NKY Pharmaceuticals Ltd, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 5 Pharmatrans-Sanaq, 5 Prachin Chemical, 4 Vasa Pharmachem, 3 Ulanqab Kema New Material, 3 Kima Chemical, 3 DKSH, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Alcedo Pharmachem, 2 Jai Radhe Sales, 2 Nanjing Well Pharmaceutical, 2 Rochem International Inc, 2 The Dow Chemical Company, 1 NEWEDGE Overseas, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Chynops Pharma, 1 Minakem, 1 Pfanstiehl, 1 Zhejiang Huakang Pharmaceutical, 1 ACG Worldwide, 1 Qualicaps, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 44 Disintegrants & Superdisintegrants, 43 Direct Compression, 26 Granulation, 24 Controlled & Modified Release, 21 Lubricants & Glidants, 20 Chewable & Orodispersible Aids, 18 Thickeners and Stabilizers, 18 Taste Masking, 16 Co-Processed Excipients, 15 Film Formers & Plasticizers, 11 Solubilizers, 8 Parenteral, 6 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 316 Finished Drug Prices

MARKET PLACE

31 APIs, 12 DOSSIERS // FDF

PATENTS

6 Health Canada Patents

6 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 2 Analytical Solutions, 3 EDQM Standards, 2 USP Standards, 18 Other Ref. Standards

DIGITAL CONTENT

5 Data Compilations & Company Tracker #PharmaFlow, 41 News

Reset Filter

Price Info

Jiangsu Zhongbang Pharmaceutical Co...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

2-n-Propyl-4-Methyl-6-(1-Methyl Benzimidazole-2-yl)Benz...

PDF Supplier PDF

URL Supplier Web Content

CAS Number

152628-02-9

End Use API

Telmisartan

About The Company

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has bee...

Jiangsu Zhongbang Pharmaceutical Co., Ltd. is a wholly-owned subsidiary of Red Sun Group. Company has been founded since 2001 and occupied 100,000m2. Company has 80 million RMB registered capital and plan to have a total investment of 200 million RMB. Company has 168 employees at present, in which there are 34 employees with Bachelor’s Degree or above, 12 employees with Master’s Degree or above, each kind of professional talents have occupied over 60% of the total employees. Company has got China GMP certificate since 2006 and currently has one GMP plant for API and one GMP plant for solid finished products. There are two production lines in API GMP plants with annual capacity of 50 tons API. There are equipment for tablets, capsules and granules in solid finished products. Company has set up qualified documentation systems according to China GMP and Europe and USA C-GMP. Company has the plan to pass COS and FDA authentication both around 2014. Company also pays serious attention on public welfare and concerns on green energy conservation and environmental protection undertaking.

ASK
US